<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FT942-1364</title>
	</head>
	<body>
		<main>
			<p>940624 FT  24 JUN 94 / Observer: Not tonight No great headaches for analysts trying to work out the logic of the latest alliance in the burgeoning international healthcare business. Glaxo, the Goliath of European drug production, is buying research from a Californian David, the 10-strong biotechnology company, Spectra. The research is into migraine; among the millions of sufferers are none other than Sir Richard Sykes - Glaxo's chief executive - and Steve Peroutka, Spectra's president.</p>
		</main>
</body></html>
            